Published in Stroke Res Treat on June 12, 2011
Copeptin, procalcitonin and routine inflammatory markers-predictors of infection after stroke. PLoS One (2012) 1.01
Lipopolysaccharide binding protein, interleukin-10, interleukin-6 and C-reactive protein blood levels in acute ischemic stroke patients with post-stroke infection. J Neuroinflammation (2015) 0.88
A simple prediction score for developing a hospital-acquired infection after acute ischemic stroke. J Stroke Cerebrovasc Dis (2015) 0.86
Respiratory infections in acute stroke: nasogastric tubes and immobility are stronger predictors than dysphagia. Dysphagia (2014) 0.85
Systemic inflammatory response syndrome in tissue-type plasminogen activator-treated patients is associated with worse short-term functional outcome. Stroke (2013) 0.80
Study protocol: prediction of stroke associated infections by markers of autonomic control. BMC Neurol (2014) 0.76
Predictors of early infection in cerebral ischemic stroke. J Med Life (2016) 0.75
Blood/Brain Biomarkers of Inflammation After Stroke and Their Association With Outcome: From C-Reactive Protein to Damage-Associated Molecular Patterns. Neurotherapeutics (2016) 0.75
Potential specific immunological indicators for stroke associated infection are partly modulated by sympathetic pathway activation. Oncotarget (2016) 0.75
Infections Up to 76 Days After Stroke Increase Disability and Death. Transl Stroke Res (2017) 0.75
The Randomized Controlled STRAWINSKI Trial: Procalcitonin-Guided Antibiotic Therapy after Stroke. Front Neurol (2017) 0.75
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke (1993) 29.81
Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis (2008) 7.17
Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med (2003) 3.89
Minocycline treatment in acute stroke: an open-label, evaluator-blinded study. Neurology (2007) 3.82
Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicine. Stroke (2003) 3.53
Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression. Stroke (2007) 2.87
Medical complications after stroke: a multicenter study. Stroke (2000) 2.81
Stroke-induced immunodepression: experimental evidence and clinical relevance. Stroke (2007) 2.76
Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial. PLoS One (2008) 2.39
The effect of pneumonia on mortality among patients hospitalized for acute stroke. Neurology (2003) 2.36
Infarct volume is a major determiner of post-stroke immune cell function and susceptibility to infection. Stroke (2009) 2.28
Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. RANTTAS Investigators. Stroke (1998) 2.22
Complications after acute stroke. Stroke (1996) 2.21
Predictors of in-hospital mortality and attributable risks of death after ischemic stroke: the German Stroke Registers Study Group. Arch Intern Med (2004) 2.16
Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial. Neuroscience (2008) 1.75
Impact of neurological and medical complications on 3-month outcomes in acute ischaemic stroke. Eur J Neurol (2008) 1.58
Analysis of lymphocyte subsets in patients with stroke and their influence on infection after stroke. Stroke (2007) 1.50
Catecholamines, infection, and death in acute ischemic stroke. J Neurol Sci (2006) 1.49
Stroke-associated infection is an independent risk factor for poor outcome after acute ischemic stroke: data from the Netherlands Stroke Survey. Cerebrovasc Dis (2009) 1.46
The Early Systemic Prophylaxis of Infection After Stroke study: a randomized clinical trial. Stroke (2005) 1.44
Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans. Cerebrovasc Dis (2007) 1.42
Predictors of pneumonia in acute stroke patients admitted to a neurological intensive care unit. J Neurol (2007) 1.40
The spectrum of systemic immune alterations after murine focal ischemia: immunodepression versus immunomodulation. Stroke (2009) 1.38
Risk factors for chest infection in acute stroke: a prospective cohort study. Stroke (2007) 1.25
Interleukin 10, monocytes and increased risk of early infection in ischaemic stroke. J Neurol Neurosurg Psychiatry (2006) 1.21
Validation of the National Institutes of Health Stroke Scale, modified Rankin Scale and Barthel Index in Brazil: the role of cultural adaptation and structured interviewing. Cerebrovasc Dis (2008) 1.20
Infection after acute stroke is associated with poor short-term outcome. Acta Neurol Scand (2007) 1.11
Frequency and determinants of pneumonia and urinary tract infection during stroke hospitalization. J Stroke Cerebrovasc Dis (2007) 1.05
Serum lipopolysaccharide binding protein levels predict severity of lung injury and mortality in patients with severe sepsis. PLoS One (2009) 0.98
Clinical and biochemical analysis in infection-associated stroke. Stroke (1995) 0.98
Medical complications of ischemic stroke and length of hospital stay: experience in Seattle, Washington. J Stroke Cerebrovasc Dis (2007) 0.97
Early identification of sepsis. Curr Infect Dis Rep (2010) 0.90
Assessment of relations between clinical outcome of ischemic stroke and activity of inflammatory processes in the acute phase based on examination of selected parameters. Eur Neurol (2005) 0.88
[Simple volumetry of ischemic cerebral infarction using computerized tomography. Interobserver and method comparison]. Rofo (1999) 0.77
Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet (2009) 6.04
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst (2010) 4.54
Inhaled iloprost for severe pulmonary hypertension. N Engl J Med (2002) 3.90
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet (2011) 3.07
Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium. Cancer Epidemiol Biomarkers Prev (2008) 3.05
Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med (2006) 2.58
Transcranial Doppler for predicting delayed cerebral ischemia after subarachnoid hemorrhage. Neurosurgery (2009) 2.58
Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: a microdialysis study. Crit Care Med (2008) 2.57
Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition? Stroke (2009) 2.28
Mechanical recanalization in basilar artery occlusion: the ENDOSTROKE study. Ann Neurol (2015) 2.16
Safety and efficacy of exercise training in various forms of pulmonary hypertension. Eur Respir J (2012) 1.83
Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale. Neurosurgery (2006) 1.65
Metabolic benefits of surface counter warming during therapeutic temperature modulation. Crit Care Med (2009) 1.64
Ultrathin PbS sheets by two-dimensional oriented attachment. Science (2010) 1.54
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Hum Mol Genet (2012) 1.47
Relationship between energy balance and complications after subarachnoid hemorrhage. JPEN J Parenter Enteral Nutr (2009) 1.43
Metabolic impact of shivering during therapeutic temperature modulation: the Bedside Shivering Assessment Scale. Stroke (2008) 1.42
Resuscitation and critical care of poor-grade subarachnoid hemorrhage. Neurosurgery (2009) 1.29
CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer. J Clin Oncol (2012) 1.29
Luminescent Solar Concentrators--a review of recent results. Opt Express (2008) 1.28
Nonconvulsive seizures after subarachnoid hemorrhage: Multimodal detection and outcomes. Ann Neurol (2013) 1.26
Tracheostomy in the intensive care unit: a nationwide survey. Anesth Analg (2008) 1.25
Preoperative prediction of long-term outcome in poor-grade aneurysmal subarachnoid hemorrhage. Neurosurgery (2006) 1.13
Cardiac arrhythmias after subarachnoid hemorrhage: risk factors and impact on outcome. Cerebrovasc Dis (2008) 1.11
The intrinsic renal compartment syndrome: new perspectives in kidney transplantation. Transplantation (2010) 1.10
Multimodality monitoring in neurocritical care. Crit Care Clin (2007) 1.09
Interannual atmospheric variability forced by the deep equatorial Atlantic Ocean. Nature (2011) 1.08
Nonconvulsive seizures in subarachnoid hemorrhage link inflammation and outcome. Ann Neurol (2014) 1.06
The AtProT family. Compatible solute transporters with similar substrate specificity but differential expression patterns. Plant Physiol (2004) 1.06
Left ventricular dysfunction and cerebral infarction from vasospasm after subarachnoid hemorrhage. Neurocrit Care (2010) 1.05
Glucose control after severe brain injury. Curr Opin Clin Nutr Metab Care (2008) 1.04
Long-term results of interstitial brachytherapy (LDR-Brachytherapy) in the treatment of patients with prostate cancer. World J Urol (2006) 1.03
Intracortical electroencephalography in acute brain injury. Ann Neurol (2009) 1.03
Relationship between C-reactive protein, systemic oxygen consumption, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Stroke (2011) 1.03
High-dose midazolam infusion for refractory status epilepticus. Neurology (2013) 1.02
Percutaneous tracheostomy is safe in patients with severe thrombocytopenia. Chest (2004) 1.02
Age dependency of successful recanalization in anterior circulation stroke: the ENDOSTROKE study. Cerebrovasc Dis (2013) 0.99
Diffusion in a metallic melt at the critical temperature of mode coupling theory. Phys Rev Lett (2003) 0.99
Is pentobarbital safe and efficacious in the treatment of super-refractory status epilepticus: a cohort study. Crit Care (2014) 0.99
Long-term therapy with inhaled iloprost in patients with pulmonary hypertension. Respir Med (2010) 0.98
Mutation analysis of the SLX4/FANCP gene in hereditary breast cancer. Breast Cancer Res Treat (2011) 0.97
Quantitative analysis of hemorrhage volume for predicting delayed cerebral ischemia after subarachnoid hemorrhage. Stroke (2011) 0.95
Predictors of global cognitive impairment 1 year after subarachnoid hemorrhage. Neurosurgery (2009) 0.95
Prevention of shivering during therapeutic temperature modulation: the Columbia anti-shivering protocol. Neurocrit Care (2011) 0.94
Global cerebral edema and brain metabolism after subarachnoid hemorrhage. Stroke (2011) 0.94
Yield and safety of bedside open lung biopsy in mechanically ventilated patients with acute lung injury or acute respiratory distress syndrome. Surgery (2007) 0.94
Acute effects of nimodipine on cerebral vasculature and brain metabolism in high grade subarachnoid hemorrhage patients. Neurocrit Care (2012) 0.93
Monocyte chemoattractant protein-1 predicts outcome and vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg (2008) 0.93
Renal dysfunction as an independent predictor of outcome after aneurysmal subarachnoid hemorrhage: a single-center cohort study. Stroke (2009) 0.93
Characterization of the Xanthomonas campestris pv. campestris lipopolysaccharide substructures essential for elicitation of an oxidative burst in tobacco cells. Mol Plant Microbe Interact (2005) 0.92
Liquid-liquid transition in a strong bulk metallic glass-forming liquid. Nat Commun (2013) 0.91
Radiation therapy and internet - what can patients expect? homepage analysis of german radiotherapy institutions. Strahlenther Onkol (2010) 0.91
Impact of nosocomial infectious complications after subarachnoid hemorrhage. Neurosurgery (2008) 0.90
Impact of induced normothermia on outcome after subarachnoid hemorrhage: a case-control study. Neurosurgery (2010) 0.90
Systemic glucose and brain energy metabolism after subarachnoid hemorrhage. Neurocrit Care (2010) 0.88
Transcranial Doppler ultrasound in the acute phase of aneurysmal subarachnoid hemorrhage. Cerebrovasc Dis (2009) 0.88
Dynamic arrest in multicomponent glass-forming alloys. Phys Rev Lett (2010) 0.88
Clinical response to hypertensive hypervolemic therapy and outcome after subarachnoid hemorrhage. Neurosurgery (2010) 0.88
Natalizumab therapy for highly active pediatric multiple sclerosis. JAMA Neurol (2013) 0.88
Multimodality monitoring for cerebral perfusion pressure optimization in comatose patients with intracerebral hemorrhage. Stroke (2011) 0.87
Periprocedural aspects in mechanical recanalization for acute stroke: data from the ENDOSTROKE registry. Neuroradiology (2013) 0.87
Malignant glioma grade 3 and 4: how relevant is timing of radiotherapy? Clin Neurol Neurosurg (2012) 0.86
Quantifying the origin of released Ag+ ions from nanosilver. Langmuir (2012) 0.86
Cerebral inflammatory response and predictors of admission clinical grade after aneurysmal subarachnoid hemorrhage. J Clin Neurosci (2009) 0.85
Spontaneous hyperventilation and brain tissue hypoxia in patients with severe brain injury. J Neurol Neurosurg Psychiatry (2009) 0.85
Low intensity, long-term outpatient rehabilitation in COPD: a randomised controlled trial. Respir Res (2012) 0.85
Cerebrovascular carbon dioxide reactivity and delayed cerebral ischemia after subarachnoid hemorrhage. Arch Neurol (2010) 0.85
Determination of functional residual capacity by oxygen washin-washout: a validation study. Intensive Care Med (2007) 0.85
Long-term renal toxicity in children following fractionated total-body irradiation (TBI) before allogeneic stem cell transplantation (SCT). Strahlenther Onkol (2009) 0.85
Predictors and clinical implications of shivering during therapeutic normothermia. Neurocrit Care (2007) 0.85
Anemia is associated with metabolic distress and brain tissue hypoxia after subarachnoid hemorrhage. Neurocrit Care (2010) 0.85
Vascularization and gene regulation of human endothelial cells growing on porous polyethersulfone (PES) hollow fiber membranes. Biomaterials (2005) 0.84
Predictors of long-term shunt-dependent hydrocephalus after aneurysmal subarachnoid hemorrhage. Clinical article. J Neurosurg (2010) 0.84
Effect of mannitol on brain metabolism and tissue oxygenation in severe haemorrhagic stroke. J Neurol Neurosurg Psychiatry (2010) 0.84
Real time estimation of brain water content in comatose patients. Ann Neurol (2012) 0.84
Novel method for high-throughput colony PCR screening in nanoliter-reactors. Nucleic Acids Res (2009) 0.84
Increased expression of Interleukin-13 but not Interleukin-4 in cystic fibrosis patients. J Cyst Fibros (2003) 0.83
Treatment of pulmonary arterial hypertension (PAH): updated Recommendations of the Cologne Consensus Conference 2011. Int J Cardiol (2011) 0.83
External ventricular drainage response in poor grade aneurysmal subarachnoid hemorrhage: effect on preoperative grading and prognosis. Neurocrit Care (2007) 0.83
Image-guided hypofractionated small volume radiotherapy of non-small cell lung cancer - feasibility and clinical outcome. Onkologie (2012) 0.83
Outcome of moderately dosed radiosurgery for limited brain metastases. Report of a single-center experience. Strahlenther Onkol (2010) 0.82
Germline variation in TP53 regulatory network genes associates with breast cancer survival and treatment outcome. Int J Cancer (2012) 0.82
Topiramate: a prospective study on the relationship between concentration, dosage and adverse events in epileptic patients on combination therapy. Epileptic Disord (2005) 0.82
Partial-volume segmentation for dose optimization in whole-breast radiotherapy: a comparative dosimetric and clinical analysis. Strahlenther Onkol (2009) 0.82
Predicting long-term outcome in poor grade aneurysmal subarachnoid haemorrhage patients utilising the Glasgow Coma Scale. J Clin Neurosci (2008) 0.82
Impact of premorbid hypertension on haemorrhage severity and aneurysm rebleeding risk after subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry (2013) 0.81
Cerebral microbleeds in patients with acute subarachnoid hemorrhage. Neurosurgery (2014) 0.81
Free Fatty acids and delayed cerebral ischemia after subarachnoid hemorrhage. Stroke (2012) 0.81
Therapeutic temperature modulation for fever after intracerebral hemorrhage. Neurocrit Care (2014) 0.80
Two sibs with fibrochondrogenesis. Am J Med Genet A (2004) 0.80
Transdermal nicotine replacement therapy in cigarette smokers with acute subarachnoid hemorrhage. Neurocrit Care (2011) 0.80
On the Lubensky-Nelson model of polymer translocation through nanopores. Biophys J (2012) 0.80
Development of pulmonary hypertension in adults after ventriculoatrial shunt implantation. Respiration (2008) 0.80
Nanosilver on nanostructured silica: Antibacterial activity and Ag surface area. Chem Eng J (2011) 0.80
Adjuvant radiotherapy in stage I seminoma: is there a role for further reduction of treatment volume? Acta Oncol (2005) 0.79
Status epilepticus-induced hyperemia and brain tissue hypoxia after cardiac arrest. Arch Neurol (2011) 0.79
Decreased interleukin-18 expression in BAL cells and peripheral blood mononuclear cells in adult cystic fibrosis patients. J Cyst Fibros (2004) 0.79
Probing the magnetic behavior of single nanodots. Nano Lett (2013) 0.79
Antileukemic activity and cellular effects of rhodium(III) crown thiaether complexes. Biometals (2011) 0.78
Fluid responsiveness and brain tissue oxygen augmentation after subarachnoid hemorrhage. Neurocrit Care (2014) 0.78